CCEL
Cryo-Cell International, Inc.
NASDAQ · Healthcare · Medical - Care Facilities · US
$4.28
+0.94%Year over year
Reported trailing growth
- Revenue
- -2.7%
- EBITDA
- -52.4%
- EBIT
- —
- EPS
- —
- Free cash flow
- +7.7%
- Operating cash flow
- +1.0%
Forward estimates
Based on analyst estimates
- Revenue
- -7.4%
- EBITDA
- +765.5%
- EPS
- +123.8%
Three-year CAGR
- Revenue
- +1.3%
- EBITDA
- -45.2%
- EBIT
- +6.4%
- Net income
- —
- EPS
- —
- Free cash flow
- +102.4%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of May 1, 2026